Dolors Soy Selected Research

Cloxacillin (Tegopen)

12/2021	Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis.
12/2020	Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditis.
1/2018	The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.
6/2014	Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dolors Soy Research Topics

Disease

13	Infections 01/2022 - 08/2006
10	Critical Illness (Critically Ill) 01/2022 - 08/2004
10	Endocarditis 12/2021 - 07/2007
7	Body Weight (Weight, Body) 01/2018 - 12/2003
4	Chagas Disease (American Trypanosomiasis) 12/2021 - 11/2010
4	Rheumatoid Arthritis 10/2020 - 01/2017
3	Fibrosis (Cirrhosis) 01/2022 - 01/2020
3	Septic Shock (Toxic Shock Syndrome) 08/2021 - 06/2014
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 01/2019
2	Bacterial Infections (Bacterial Infection) 01/2022 - 12/2020
2	Triple Negative Breast Neoplasms 01/2021 - 12/2019
2	Neoplasms (Cancer) 01/2021 - 07/2020
2	Bacteremia 10/2014 - 06/2014
2	Acute Kidney Injury (Acute Renal Failure) 09/2012 - 05/2012
2	Pneumonia (Pneumonitis) 08/2012 - 01/2012
1	Hypoalbuminemia 08/2021
1	Muscle Hypotonia (Hypotonia) 01/2021
1	Acute-On-Chronic Liver Failure 12/2020
1	Breast Neoplasms (Breast Cancer) 07/2020
1	Stomach Neoplasms (Stomach Cancer) 07/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Chronic Hepatitis C 01/2020
1	Empyema 12/2019
1	Neoplasm Metastasis (Metastasis) 12/2019
1	Diabetes Mellitus 01/2018
1	Cytomegalovirus Infections (Inclusion Disease) 11/2016
1	Multiple Organ Failure (MODS) 01/2016
1	Lung Diseases (Lung Disease) 01/2016
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016
1	Idiopathic Pulmonary Fibrosis 01/2016
1	Sepsis (Septicemia) 10/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2014
1	Staphylococcal Infections 06/2014
1	Tuberculosis (Tuberculoses) 12/2013
1	Drug-Related Side Effects and Adverse Reactions 01/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2012
1	Osteosarcoma (Osteogenic Sarcoma) 02/2009

Drug/Important Bio-Agent (IBA)

10	Vancomycin FDA LinkGeneric 12/2021 - 07/2007
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 08/2006
5	Pharmaceutical PreparationsIBA 01/2022 - 02/2009
5	Daptomycin FDA Link 12/2021 - 07/2008
5	Linezolid (Zyvox)FDA Link 10/2019 - 01/2012
4	Cloxacillin (Tegopen)FDA Link 12/2021 - 06/2014
3	LithiumIBA 01/2021 - 01/2019
3	Fosfomycin FDA Link 12/2020 - 10/2014
3	tocilizumab (atlizumab)FDA Link 10/2020 - 01/2018
3	Antiviral Agents (Antivirals)IBA 01/2020 - 11/2016
3	benzonidazole (benznidazole)IBA 01/2013 - 11/2010
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2021
2	Methicillin (Metin)FDA Link 12/2021 - 06/2014
2	Meropenem (Merrem)FDA LinkGeneric 12/2020 - 09/2015
2	CreatinineIBA 12/2020 - 02/2016
2	Imipenem FDA Link 10/2014 - 08/2004
2	Anti-Infective Agents (Microbicides)IBA 04/2008 - 03/2008
1	Tigecycline (Tygacil)FDA Link 01/2022
1	AlbuminsIBA 08/2021
1	benzmetanide (H 25)IBA 08/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	atezolizumabIBA 01/2021
1	Gentamicins (Gentamicin)FDA LinkGeneric 12/2020
1	Monoclonal AntibodiesIBA 10/2020
1	Formaldehyde (Formol)FDA Link 07/2020
1	ParaffinIBA 07/2020
1	human ERBB2 proteinIBA 07/2020
1	Ado-Trastuzumab EmtansineIBA 07/2020
1	Messenger RNA (mRNA)IBA 07/2020
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2020
1	dornase alfa (Pulmozyme)FDA Link 12/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2019
1	olaparibIBA 12/2019
1	Clozapine (Clozaril)FDA LinkGeneric 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Biological ProductsIBA 01/2017
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 11/2016
1	TOR Serine-Threonine KinasesIBA 11/2016
1	Cystatin CIBA 02/2016
1	Piperacillin FDA LinkGeneric 01/2016
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2016
1	CoagulaseIBA 01/2015
1	SodiumIBA 10/2014
1	beta-LactamsIBA 06/2014
1	Levofloxacin (Levaquin)FDA Link 12/2013
1	Penicillins (Penicillin)FDA Link 05/2013
1	NifurtimoxIBA 01/2013
1	Methotrexate (Mexate)FDA LinkGeneric 02/2009

Therapy/Procedure

9	Therapeutics 12/2021 - 10/2006
5	Continuous Renal Replacement Therapy 08/2021 - 09/2012
3	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2021 - 05/2012
2	Catheters 02/2016 - 08/2006
1	Drug Therapy (Chemotherapy) 12/2021
1	Immunotherapy 01/2021
1	Drug Tapering 10/2020
1	Neoadjuvant Therapy 07/2020
1	Polypharmacy 01/2020
1	Debridement 12/2019
1	Length of Stay 12/2019
1	Cell Transplantation 01/2016
1	Transplantation 01/2016
1	Intravenous Administration 02/2009